| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:58:32 UTC |
|---|
| Update Date | 2022-11-30 19:25:57 UTC |
|---|
| HMDB ID | HMDB0114881 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(18:0/20:0) |
|---|
| Description | PA(18:0/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:0/20:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCCCC InChI=1S/C41H81O8P/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2/h39H,3-38H2,1-2H3,(H2,44,45,46)/t39-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Stearoyl-2-arachidoyl-sn-glycero-3-phosphate | HMDB | | 1-Stearoyl-2-arachidoyl-sn-phosphatidic acid | HMDB | | PA(38:0) | HMDB | | Phosphatidic acid(18:0/20:0) | HMDB | | Phosphatidic acid(38:0) | HMDB | | Phosphatidate(18:0/20:0) | HMDB | | Phosphatidate(38:0) | HMDB | | 1-stearoyl-2-arachidoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-stearoyl-2-arachidoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(38:0) | SMPDB, HMDB | | Phosphatidic acid(18:0/20:0) | SMPDB, HMDB | | Phosphatidic acid(38:0) | SMPDB, HMDB | | Phosphatidate(18:0/20:0) | SMPDB, HMDB | | PA(18:0/20:0) | SMPDB |
|
|---|
| Chemical Formula | C41H81O8P |
|---|
| Average Molecular Weight | 733.065 |
|---|
| Monoisotopic Molecular Weight | 732.566906566 |
|---|
| IUPAC Name | [(2R)-2-(icosanoyloxy)-3-(octadecanoyloxy)propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-(icosanoyloxy)-3-(octadecanoyloxy)propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C41H81O8P/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2/h39H,3-38H2,1-2H3,(H2,44,45,46)/t39-/m1/s1 |
|---|
| InChI Key | WSHAXIXHAXRXGT-LDLOPFEMSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Phosphatidylcholine Biosynthesis PC(18:0/20:0) (PathBank: SMP0063836)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0065951)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/22:2(13Z,16Z)) (PathBank: SMP0065954)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0065955)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0065957)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/24:0) (PathBank: SMP0065959)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:2(11Z,14Z)) (PathBank: SMP0074697)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0074698)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0074707)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/24:1(15Z)) (PathBank: SMP0089980)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0096073)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099275)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099284)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:1(11Z)) (PathBank: SMP0065945)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/22:1(13Z)) (PathBank: SMP0065953)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0065958)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/22:0) (PathBank: SMP0074703)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:0) (PathBank: SMP0089963)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:1(11Z)) (PathBank: SMP0099274)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/22:0) (PathBank: SMP0099277)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099285)
- Cardiolipin Biosynthesis CL(18:0/20:0/22:1(13Z)/22:1(13Z)) (PathBank: SMP0099293)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0065948)
- Phosphatidylethanolamine Biosynthesis PE(18:0/20:0) (PathBank: SMP0071738)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0074701)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:0) (PathBank: SMP0084687)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099276)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(11Z)/22:1(13Z)) (PathBank: SMP0099283)
- Cardiolipin Biosynthesis CL(18:0/20:0/22:0/22:0) (PathBank: SMP0099291)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/22:1(13Z)) (PathBank: SMP0099278)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(11Z)/20:1(11Z)) (PathBank: SMP0099279)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(11Z)/22:0) (PathBank: SMP0099282)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099288)
- Cardiolipin Biosynthesis CL(18:0/20:0/22:0/22:1(13Z)) (PathBank: SMP0099292)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/18:0) (PathBank: SMP0018326)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/14:1(9Z)) (PathBank: SMP0018329)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/16:1(9Z)) (PathBank: SMP0018330)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/18:1(11Z)) (PathBank: SMP0018331)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/18:1(9Z)) (PathBank: SMP0018332)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/18:2(9Z,12Z)) (PathBank: SMP0018336)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0018337)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0018341)
- De Novo Triacylglycerol Biosynthesis TG(18:0/20:0/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0018342)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:1(13Z)) (PathBank: SMP0081484)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(11Z)/20:1(13Z)) (PathBank: SMP0081488)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(13Z)/20:1(13Z)) (PathBank: SMP0081491)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(13Z)/22:0) (PathBank: SMP0081492)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(13Z)/22:1(13Z)) (PathBank: SMP0081493)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0084688)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0084689)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084693)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0084694)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0084695)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084696)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084697)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084698)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0084699)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0084700)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0084701)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084702)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084705)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084707)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0084708)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099280)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099281)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0099286)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0099287)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0099289)
- Cardiolipin Biosynthesis CL(18:0/20:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0099290)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 10.1 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 37.5309 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.41 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5366.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 693.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 403.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 270.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1062.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1825.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1711.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 235.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3745.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1125.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 3053.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1446.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 759.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 889.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 857.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(18:0/20:0),1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 5109.8 | Semi standard non polar | 33892256 | | PA(18:0/20:0),1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4617.4 | Standard non polar | 33892256 | | PA(18:0/20:0),1TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 6187.5 | Standard polar | 33892256 | | PA(18:0/20:0),2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 5065.2 | Semi standard non polar | 33892256 | | PA(18:0/20:0),2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4615.6 | Standard non polar | 33892256 | | PA(18:0/20:0),2TMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 5419.6 | Standard polar | 33892256 | | PA(18:0/20:0),1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5409.1 | Semi standard non polar | 33892256 | | PA(18:0/20:0),1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4721.8 | Standard non polar | 33892256 | | PA(18:0/20:0),1TBDMS,isomer #1 | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 6131.3 | Standard polar | 33892256 |
|
|---|